Sanofi executives “confirm to the president that the group shares the French approach to universal access to the vaccine in order to make it a global public good,” said the Elysee Palace in a statement.
Macron called the chairman, chief executive officer and president of the company to a meeting on Tuesday after CEO Paul Hudson said last week that “the US government is entitled to the biggest pre-order because it is invested in risk taking ”.
Hudson was speaking to Bloomberg News.
French officials responded angrily to Hudson’s remarks, with Deputy Minister of Finance Agnès Pannier-Runacher saying: “It would be unacceptable for Sanofi to reserve his Covid-19 vaccine first, if he finds one, in a country or another. for financial reasons. “
Sanofi spokesman Jean-Baptiste Froville said in a statement on Friday that Hudson’s comments had been misinterpreted.
Sanofi chairman Serge Weinberg, chairman Olivier Bogillot and CEO Hudson met Macron on Tuesday 45 minutes, said Macron’s office.
The Elysée press release added that Sanofi “is fully committed to its presence in France”.
There was no immediate statement from Sanofi after the meeting.
This story was first published on CNN.com, “Vaccine manufacturer forgoes priority access in the United States, according to France”